← All investigations

Case file 15 / Science & Discovery

The Clear Zone

An antibacterial observation is not yet a usable medicine.

Discovery of penicillin · 9 min · 4 evidence exhibits · 3 reasoning steps

Follow the record.
Question the explanation.

01 / The briefing

Begin with the question.

In 1928, Alexander Fleming observed that a mold could inhibit nearby bacteria. That observation became famous, but the familiar accident story can hide the harder questions. Was there a transferable substance? Could it be measured reliably? Could enough active material be prepared, tested, and supplied? The Oxford team’s later work, involving Florey, Chain, Heatley, Abraham, and others, addressed problems that a single culture plate could not answer. Your investigation follows that chain of evidence without treating a laboratory inhibition zone as proof of safety or clinical effectiveness. These are historical scientific reasoning exercises, not instructions for culturing organisms or making medicines. The aim is to distinguish a promising biological effect from a reproducible substance, then from a practical intervention. Each transition requires different evidence and different expertise.

The timeline

  1. Fleming discovers the antibacterial effect associated with a Penicillium mold.

  2. Fleming publishes his findings on penicillin.

  3. Chain and Florey begin Oxford work on penicillin within a broader antibacterial research program.

  4. Oxford experiments demonstrate protective effects in infected mice.

  5. Oxford clinical work brings penicillin into patient treatment.

  6. Fleming, Florey, and Chain share the Nobel Prize.

A researched reconstruction for learning. These reasoning steps simplify a complex record; no score can capture the full history.

02 / The evidence

What does the record show?

Read each exhibit before settling on an explanation. The numbered source links below every exhibit lead to the record behind it.

Exhibit 01

An effect near the mold

The original finding concerned a diffusible substance inhibiting some bacteria. It was not evidence that all microbes or all diseases would respond.

Source record [s1]

Exhibit 02

Measure activity, not appearance

Heatley developed a sensitive assay for antibacterial activity. A reliable comparison of preparations was necessary because visible material and active drug are not the same thing.

Source record [s1]

Exhibit 03

A difficult preparation

Instability and preparation problems stood between an initial observation and a usable product. Extraction, testing, and production required a team rather than observation alone.

Source record [s1]

Exhibit 04

Different questions, different tests

Animal protection experiments and later patient treatment supplied evidence beyond inhibition on a plate. Large-scale manufacturing then addressed whether useful quantities could be supplied.

Source record [s2]

03 / Your reasoning

Follow the strongest explanation.

Choose an interpretation, then compare it with the evidence. You can revise your choice. The goal is understanding, not a perfect score.

Reasoning step 01

Reasoning step 1

What does the clear region initially support?

Evidence-based explanation

A local laboratory effect supports a limited antibacterial claim. Safety, scope, and treatment benefit require separate evidence.

Consider: Exhibit 01, Exhibit 02, Exhibit 03, Exhibit 04. Follow their source links to check the record.

Reasoning step 02

Reasoning step 2

Why is a reproducible activity assay a key development?

Evidence-based explanation

A consistent assay helps determine what a preparation actually does. It does not remove other development requirements or identify every constituent as useful.

Consider: Exhibit 01, Exhibit 02, Exhibit 03, Exhibit 04. Follow their source links to check the record.

Reasoning step 03

Reasoning step 3

Which account best explains the transition to medicine?

Evidence-based explanation

The stages are complementary. Discovering an effect and turning it into a dependable treatment answer different questions; neither erases the other.

Consider: Exhibit 01, Exhibit 02, Exhibit 03, Exhibit 04. Follow their source links to check the record.

04 / The findings

The chain behind the outcome.

Penicillin’s story is not a choice between an accidental discovery and deliberate research. An unexpected observation mattered because it was recognized and investigated. Its practical value then depended on work that solved measurement, preparation, biological testing, clinical, and production problems. Fleming’s contribution and the Oxford team’s development were distinct and essential parts of that sequence. Heatley’s methods and the efforts of many laboratory and manufacturing workers should not disappear behind a three-name prize list. The case also demonstrates a limit on inference: inhibition of bacteria in a dish does not alone establish safety, an effective dose, or benefit for a patient. Historical success should not make that leap seem justified. The general lesson is to identify exactly which claim each experiment supports, then design the next test for the remaining gap instead of treating promise as completion.

Take the method with you

  • An observed biological effect is not yet a treatment.
  • Reliable measurement can be as important as the initial discovery.
  • Scientific credit should include development and production work.

You can read findings at any time. Exploring every reasoning step marks this case as complete in your notebook.

Open another investigation

The open record

Sources & further reading

Read the original record and its scope before relying on a conclusion. Source references support the exhibit summaries; Faultory’s reasoning prompts are editorial reconstructions.

  1. s1
  2. s2
  3. s3

Written and curated for Faultory by Yunus Emre Vurgun, with AI-assisted research and drafting. Sources and interpretations can need correction. Read our editorial standards or report an issue.